Sarah Tasian, MD, on Advances, Challenges in Pediatric Hematologic Oncology at ASH 2022

Sarah Tasian, MD, of the Children’s Hospital of Philadelphia, talks with The HemOnc Pulse about pediatric oncology during the 64th American Society of Hematology Annual Meeting and Exposition. Dr. Tasian discussed the unique pediatric biology of childhood hematologic malignancies, data presented at ASH on an antibody-drug conjugate that led to “remarkable” responses in a type of pediatric leukemia, advances in targeted immunotherapies for pediatric patients, continuing challenges, and more.